Back to calendar
Evommune, Inc. (EVMN) Earnings
EVMN reports earnings on Thursday, December 10, 2026
earnings report
December 10, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.83
Actual EPS: $-0.89
EPS surprise: -33.94%
Company overview
Market Cap$219.6M
PriceUSD 6.05
EPS (TTM)-2.83
52-week high33.20
52-week low4.94
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees48